ratiopharm Group
Division of Teva Pharmaceutical Industries Ltd.
www1.ratiopharm.com
Latest From ratiopharm Group
Generics Players Dominating New OTC Launches In Germany
An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.
Generics Players Dominating New OTC Launches In Germany
An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.
Germany Approves Trilogy Of Switches
Three prescription-to-OTC switches approved in Germany: Levocetirizine for oral use, diclofenac for use as a patch, and preparations containing sodium bituminosulfonate and hydrocortisone acetate.
German Expert Panel Opposes OTC Ibuprofen/Phenylephrine Combo, Hydrocortisone 1%
Two prescription-to-OTC switch applications rejected by Germany’s Expert Committee for Prescription: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
- Therapeutic Areas
- Non-Specific
- Alias(es)
- ratiopharm GMBH
- Magnafarma
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
- Oliver Windholtz, CEO
- Contact Info
-
ratiopharm Group
Phone: (49) 731 402 02
Graf-Arco-Strasse 3
P.O. Box 3380 Ulm, 89079
Germany
Advertisement
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ratiopharm Group
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice